The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Coming back to: Half-life, steady state, and accumulation worked through

This is a generated summary. It shows the 5 most-liked posts from a topic of 19, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
SD
s.dziedzicTL27 Apr 2026 · edited#8

Washout after stopping takes roughly the same four to five half-lives as reaching steady state. A month after the last dose is not the same as none.

I checked the source rather than the summary, and they differ.

18 likes 4mo
CR
compounding_ruthTL4Pharmacist8 Apr 2026 · edited#9

Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady state and how long it takes to clear after stopping.

Nothing above should be read as advice about what anyone else should do.

19 likes 4mo
MB
ma.balogunTL210 Apr 2026#11
a.silva, post #3: A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model will not tell you it is. Where I would look next, rather than where I would stop. Go to post

Post #7 describes the usual case. This is about the unusual one.

What I can speak to on Half-life is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.

22 likes in reply to #3 4mo
DN
d.nilsenTL213 Apr 2026#15
va.baptista, post #6: Everything in post #4 holds. The case it does not cover is the one I have. A note on how Half-life gets discussed rather than on Half-life itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been right more often. Go to post

No notes. Posting so the count is not one.

16 likes in reply to #6 3mo
O
OTeixeiraTL3Regular16 Apr 2026#18

Genuine question rather than a rhetorical one: has anyone here actually observed Half-life, as opposed to read about it? The thread is long and I cannot tell.

31 likes 3mo

Read the full topic (19 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Half-life, steady state, and accumulation worked through
Half-life, steady state, and accumulation worked through Writing it up because I had to work it out twice and would rather nobody else did. Working through the kinetics rather than the pharmacology, because I…
OVJSRPTS+115 130 44k 13mo
Peak-to-trough ratio at steady state for a weekly agent — the long version
Peak-to-trough ratio at steady state for a weekly agent — the long version Writing it up because I had to work it out twice and would rather nobody else did. A narrow question about Peak-to-trough ratio,…
CTRSWAVUC+57 61 708 1d
Clearance pathways and what renal impairment changes
Clearance pathways and what renal impairment changes Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of clearance pathways is wrong? I…
BAWADAKLS+11 15 43k 2mo
Half-life, steady state, and accumulation worked through — a second dataset
Half-life, steady state, and accumulation worked through — a second dataset — setting out what I have, and where I think it stops being reliable. Working through the kinetics rather than the pharmacology,…
EDRFCHLIAK+110 126 14k 4mo
Second pass at: Albumin binding and how it produces a long half-life
Posting this under the heading it deserves: Second pass at: Albumin binding and how it produces a long half-life Everything below is what sits behind that. A narrow question about Albumin binding,…
BRIJVPYR+7 11 31k 17mo

Related topics — sharing the tags tirzepatide, liraglutide, worked example

TopicParticipantsRepliesViewsActivity
Designing a personal experiment that could change your mind
Posting this under the heading it deserves: Designing a personal experiment that could change your mind Everything below is what sits behind that. I was wrong about designing a personal experiment in a thread…
MGECFACHG+2 6 695 6mo
[2026 update] Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA
Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA — setting out what I have, and where I think it stops being reliable. Reading back through what has been written here about Tirzepatide in…
TTSIKR 2 58k 11mo
Tracking semaglutide's approved indications across jurisdictions, dated
Tracking semaglutide's approved indications across jurisdictions, dated Writing it up because I had to work it out twice and would rather nobody else did. Putting the numbers in the first post, because a…
PIISGRWN+15 19 2.8k 1d
SURMOUNT-4 and what withdrawal data does and does not tell an individual
SURMOUNT-4 and what withdrawal data does and does not tell an individual — setting out what I have, and where I think it stops being reliable. I would like to disagree carefully with the settled view on…
NSLMAADKA 4 42k 11mo
Second pass at: Absence of evidence and evidence of absence
On the subject in the title: Second pass at: Absence of evidence and evidence of absence Working notes rather than a conclusion. Two things I would like separated before anyone answers on Absence of evidence,…
SLMFEMRHSR+50 55 18k 16h